US Stock MarketDetailed Quotes

VTYX Ventyx Biosciences

Watchlist
  • 2.240
  • -0.040-1.75%
Close Dec 20 16:00 ET
  • 2.240
  • 0.0000.00%
Post 18:17 ET
158.39MMarket Cap-0.95P/E (TTM)

Ventyx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-33.47%38.55M
-37.51%35.71M
-1.84%41.77M
83.84%207.99M
30.53%50.35M
84.44%57.95M
180.15%57.15M
87.07%42.55M
68.49%113.14M
116.37%38.57M
Selling and administrative expenses
-3.39%7.92M
-7.90%7.91M
12.73%8.02M
26.89%32.23M
-0.72%8.33M
37.79%8.2M
50.03%8.59M
33.29%7.12M
193.08%25.4M
109.55%8.39M
-General and administrative expense
-3.39%7.92M
-7.90%7.91M
12.73%8.02M
26.89%32.23M
-0.72%8.33M
37.79%8.2M
50.03%8.59M
33.29%7.12M
193.08%25.4M
109.55%8.39M
Research and development costs
-38.43%30.63M
-42.74%27.81M
-4.77%33.75M
100.33%175.77M
39.21%42.02M
95.34%49.75M
230.88%48.56M
103.56%35.44M
50.03%87.74M
118.35%30.19M
Operating profit
33.47%-38.55M
37.51%-35.71M
1.84%-41.77M
-83.84%-207.99M
-30.53%-50.35M
-84.44%-57.95M
-180.15%-57.15M
-87.07%-42.55M
-68.49%-113.14M
-116.37%-38.57M
Net non-operating interest income expense
-14.80%3.35M
-2.98%3.78M
-10.91%3.23M
222.85%15.07M
13.69%3.62M
289.31%3.93M
1,040.06%3.9M
2,643.94%3.62M
22,333.33%4.67M
3,983.33%3.19M
Non-operating interest income
-14.80%3.35M
-2.98%3.78M
-10.91%3.23M
222.85%15.07M
13.69%3.62M
289.31%3.93M
1,040.06%3.9M
2,643.94%3.62M
5,885.90%4.67M
--3.19M
Other net income (expense)
-487.50%-47K
-320.00%-21K
-3,000.00%-31K
-202.44%-42K
-116.28%-28K
84.62%-8K
-113.16%-5K
99.15%-1K
100.25%41K
960.00%172K
Other non- operating income (expenses)
-487.50%-47K
-320.00%-21K
-3,000.00%-31K
-202.44%-42K
-116.28%-28K
84.62%-8K
-113.16%-5K
99.15%-1K
100.74%41K
960.00%172K
Income before tax
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-77.97%-192.96M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-29.47%-108.43M
-98.19%-35.21M
Income tax
Net income
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-77.97%-192.96M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-29.47%-108.43M
-98.19%-35.21M
Net income continuous Operations
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-77.97%-192.96M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-29.47%-108.43M
-98.19%-35.21M
Minority interest income
Net income attributable to the parent company
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-77.97%-192.96M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-29.47%-108.43M
-98.19%-35.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-77.97%-192.96M
-32.77%-46.75M
-77.36%-54.03M
-166.02%-53.25M
-71.26%-38.93M
-27.11%-108.43M
-98.19%-35.21M
Basic earnings per share
45.65%-0.5
50.55%-0.45
8.82%-0.62
-59.42%-3.3
-27.42%-0.79
-55.93%-0.92
-133.33%-0.91
-51.11%-0.68
68.87%-2.07
-75.90%-0.62
Diluted earnings per share
45.65%-0.5
50.55%-0.45
8.82%-0.62
-59.42%-3.3
-27.42%-0.79
-55.93%-0.92
-133.33%-0.91
-51.11%-0.68
68.87%-2.07
-75.90%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -33.47%38.55M-37.51%35.71M-1.84%41.77M83.84%207.99M30.53%50.35M84.44%57.95M180.15%57.15M87.07%42.55M68.49%113.14M116.37%38.57M
Selling and administrative expenses -3.39%7.92M-7.90%7.91M12.73%8.02M26.89%32.23M-0.72%8.33M37.79%8.2M50.03%8.59M33.29%7.12M193.08%25.4M109.55%8.39M
-General and administrative expense -3.39%7.92M-7.90%7.91M12.73%8.02M26.89%32.23M-0.72%8.33M37.79%8.2M50.03%8.59M33.29%7.12M193.08%25.4M109.55%8.39M
Research and development costs -38.43%30.63M-42.74%27.81M-4.77%33.75M100.33%175.77M39.21%42.02M95.34%49.75M230.88%48.56M103.56%35.44M50.03%87.74M118.35%30.19M
Operating profit 33.47%-38.55M37.51%-35.71M1.84%-41.77M-83.84%-207.99M-30.53%-50.35M-84.44%-57.95M-180.15%-57.15M-87.07%-42.55M-68.49%-113.14M-116.37%-38.57M
Net non-operating interest income expense -14.80%3.35M-2.98%3.78M-10.91%3.23M222.85%15.07M13.69%3.62M289.31%3.93M1,040.06%3.9M2,643.94%3.62M22,333.33%4.67M3,983.33%3.19M
Non-operating interest income -14.80%3.35M-2.98%3.78M-10.91%3.23M222.85%15.07M13.69%3.62M289.31%3.93M1,040.06%3.9M2,643.94%3.62M5,885.90%4.67M--3.19M
Other net income (expense) -487.50%-47K-320.00%-21K-3,000.00%-31K-202.44%-42K-116.28%-28K84.62%-8K-113.16%-5K99.15%-1K100.25%41K960.00%172K
Other non- operating income (expenses) -487.50%-47K-320.00%-21K-3,000.00%-31K-202.44%-42K-116.28%-28K84.62%-8K-113.16%-5K99.15%-1K100.74%41K960.00%172K
Income before tax 34.76%-35.25M40.00%-31.95M0.92%-38.57M-77.97%-192.96M-32.77%-46.75M-77.36%-54.03M-166.02%-53.25M-71.26%-38.93M-29.47%-108.43M-98.19%-35.21M
Income tax
Net income 34.76%-35.25M40.00%-31.95M0.92%-38.57M-77.97%-192.96M-32.77%-46.75M-77.36%-54.03M-166.02%-53.25M-71.26%-38.93M-29.47%-108.43M-98.19%-35.21M
Net income continuous Operations 34.76%-35.25M40.00%-31.95M0.92%-38.57M-77.97%-192.96M-32.77%-46.75M-77.36%-54.03M-166.02%-53.25M-71.26%-38.93M-29.47%-108.43M-98.19%-35.21M
Minority interest income
Net income attributable to the parent company 34.76%-35.25M40.00%-31.95M0.92%-38.57M-77.97%-192.96M-32.77%-46.75M-77.36%-54.03M-166.02%-53.25M-71.26%-38.93M-29.47%-108.43M-98.19%-35.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.76%-35.25M40.00%-31.95M0.92%-38.57M-77.97%-192.96M-32.77%-46.75M-77.36%-54.03M-166.02%-53.25M-71.26%-38.93M-27.11%-108.43M-98.19%-35.21M
Basic earnings per share 45.65%-0.550.55%-0.458.82%-0.62-59.42%-3.3-27.42%-0.79-55.93%-0.92-133.33%-0.91-51.11%-0.6868.87%-2.07-75.90%-0.62
Diluted earnings per share 45.65%-0.550.55%-0.458.82%-0.62-59.42%-3.3-27.42%-0.79-55.93%-0.92-133.33%-0.91-51.11%-0.6868.87%-2.07-75.90%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List